$196M sweet spot round size
Most of their 13 investments are in rounds between $120M and $230M
1980
NorthLink Aviation raised undisclosed on December 1, 2021
Investors: Alaska Permanent Fund Corporation
Generate Biomedicines, Inc. raised $370M on November 18, 2021
Investors: ARCH Venture Partners, Abu Dhabi Investment Authority (ADIA), Morningside Venture Capital 晨兴资本, T. Rowe Price, Flagship Ventures and Alaska Permanent Fund Corporation
Repertoire Immune Medicines raised $189M on April 13, 2021
Investors: The Invus Group, SoftBank Investment Advisers, Flagship Ventures and Alaska Permanent Fund Corporation
Tessera Therapeutics raised $230M on January 12, 2021
Investors: Longevity Vision Fund, Qatar Investment Authority, SoftBank Investment Advisers, Flagship Ventures and Alaska Permanent Fund Corporation
Indigo raised $360M on August 3, 2020
Investors: Empede Capital, Flagship Ventures and Alaska Permanent Fund Corporation
Indigo raised $250M on September 18, 2018
Investors: Investment Corporation of Dubai, CEAS Investments, Flagship Ventures, Baillie Gifford and Alaska Permanent Fund Corporation
Indigo raised $203M on September 26, 2017
Investors: CEAS Investments, Investment Corporation of Dubai, Flagship Ventures, Baillie Gifford and Alaska Permanent Fund Corporation
Denali Therapeutics raised $130M on August 25, 2016
Investors: ARCH Venture Partners, Baillie Gifford, F-Prime Capital Partners, Flagship Ventures and Alaska Permanent Fund Corporation
Indigo raised $100M on July 21, 2016
Investors: CEAS Investments, Flagship Ventures, Olive Tree Capital and Alaska Permanent Fund Corporation
Undisclosed raised $61M on January 26, 2016
Investors: Yukon Partners, ARCH Venture Partners, Flagship Ventures and Alaska Permanent Fund Corporation